Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 7 August 2008, doi:10.1136/bmj.a636
Cite this as: BMJ 2008;337:a636
Tobias Kurth, assistant professor of medicine1,2,3, Markus Schürks, research fellow in medicine1, Giancarlo Logroscino, associate professor of neurology4, J Michael Gaziano, associate professor of medicine1,2,5, Julie E Buring, professor of medicine1,2,3,6
1 Division of Preventive Medicine, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, USA, 2 Division of Aging, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, 3 Department of Epidemiology, Harvard School of Public Health, Boston, MA, 4 Department of Neurology and Psychiatry, School of Medicine, University of Bari, Italy, 5 Massachusetts Veterans Epidemiology Research and Information Center, Boston VA Healthcare System, Boston, MA, 6 Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA
Correspondence to: T Kurth tkurth{at}rics.bwh.harvard.edu
Design Prospective cohort study.
Setting Womens health study, United States.
Participants 27 519 women who were free from cardiovascular disease at baseline with available information on the Framingham risk score and migraine status.
Main outcome measures Time to major cardiovascular disease event (non-fatal myocardial infarction, non-fatal ischaemic stroke, death from ischaemic cardiovascular disease), myocardial infarction, and ischaemic stroke.
Results At baseline, 3577 (13.0%) women reported active migraine, of whom 1418 (39.6%) reported migraine with aura. During 11.9 years of follow-up, there were 697 cardiovascular disease events. We stratified participants based on 10 year risk of coronary heart disease estimated from the Framingham risk score (
1%, 2-4%, 5-9%, and
10%). Compared with women without migraine, the age adjusted hazard ratios in women with active migraine with aura were 1.93 (95% confidence interval 1.45 to 2.56) for major cardiovascular disease, 1.80 (1.16 to 2.79) for ischaemic stroke, and 1.94 (1.27 to 2.95) for myocardial infarction. When stratified by Framingham risk score, the association between migraine with aura and major cardiovascular disease was strongest in the lowest risk score group. There was a diametric association pattern for ischaemic stroke and myocardial infarction. Compared with women without migraine, the age adjusted hazard ratios in women who reported migraine with aura in the lowest Framingham risk score group were 3.88 (1.87 to 8.08) for ischaemic stroke and 1.29 (0.40 to 4.21) for myocardial infarction. Hazard ratios in women with migraine with aura in the highest Framingham risk score group were 1.00 (0.24 to 4.14) for ischaemic stroke and 3.34 (1.50 to 7.46) for myocardial infarction. Women with migraine without aura were not at increased risk of ischaemic stroke or myocardial infarction in any of the Framingham risk score groups.
Conclusion The association between migraine with aura and cardiovascular disease varies by vascular risk status. Information on history of migraine and vascular risk status might help to identify women at increased risk for specific future cardiovascular disease events.
Trial registration Clinical trials NCT00000479 [ClinicalTrials.gov] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses